SCARB1 and diabetic kidney disease: Compared with non-DKD, the degree of glycation of high-density lipoprotein in DKD is higher, and hyperglycemia leads to an increase in the production of advanced glycation end products (AGE), inhibiting PON-1 activity and the binding of HDL with SR-BI [97].